Fig. 9

a Immunohistochemical staining for COX-II, NFκB and TNF-α in control (A1-A12), CC (B1-B12) group. b Immunohistochemical staining for COX-II, NFκB and TNF-α in HA-TC-NDV (C1-C12) and pure NDV treatment (D1-D12) group